表紙
市場調査レポート

欧州の細胞表面検査市場(病院・民間試験所・外来治療センター向け)

2016-2020 Future Horizons and Growth Strategies in the EU5 Cell Surface Marker Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities

発行 Venture Planning Group 商品コード 273984
出版日 ページ情報 英文 125 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。

Local License: 同一事業所内

Back to Top
欧州の細胞表面検査市場(病院・民間試験所・外来治療センター向け) 2016-2020 Future Horizons and Growth Strategies in the EU5 Cell Surface Marker Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities
出版日: ページ情報: 英文 125 Pages
概要

当レポートでは、欧州主要5ヶ国の各種医療機関(病院・民間試験所・外来治療センターなど)向けの細胞表面検査の関連市場について分析し、技術の概要や開発・活用の最新状況、市場動向の見通し(今後5年間分)、主要サプライヤーの市場シェア、今後の市場機会と課題、主要企業のプロファイルと市場戦略といった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界の市場・技術の概要

  • リンパ球の詳細分類:CD4/CD8/CD34
  • CD34
  • その他の細胞市場
  • 装置レビュー
    • 血液分析装置
    • フローサイトメトリー
  • 血液分析装置の現在の市場ニーズと将来的需要
  • 試薬とコントロール
  • 現在・新規の技術
    • 情報技術(IT)
    • オートメーション・ロボット工学
    • レーザー
    • モノクローナル抗体
    • 分子診断
    • マイクロドロップ技術

フランス市場:検査項目・市場分類別の予測

ドイツ市場:検査項目・市場分類別の予測

イタリア市場:検査項目・市場分類別の予測

スペイン市場:検査項目・市場分類別の予測

英国市場:検査項目・市場分類別の予測

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の細分化

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業分析

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • 堀場製作所
  • Iris/Danaher
  • 日本光電
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • シスメックス

付録:血液検査/フローサイトメトリー技術とその応用分野を開発している主な大学・研究機関

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPHFC17843

The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.

Rationale

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains: 125 pages and 24 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Lymphocyte Subclassification CD4/CD8/CD34
    • Instrumentation and Reagent Test Kits
      • BD
      • Beckman Coulter/Danaher
      • T Cells Diagnostics
  • B. CD34
  • C. Other Cell Markers
  • D. Instrumentation Review
    • 1. Hematology Analyzers
      • a. Overview
        • Electrical Aperture-Impedance Analyzers
        • Light Scatter Analyzers
      • b. System Review
        • Abbott
        • Beckman Coulter/Danaher
        • Biocode Hycel
        • Drew-Scientific
        • Horiba
        • Menarini
        • Nihon Kohden
        • Siemens
        • Sysmex
    • 2. Flow Cytometers
      • a. Introduction
      • b. System Overview
        • Becton Dickinson
        • Beckman Coulter/Danaher
  • E. Current Market Needs and Future Demand For Hematology Analyzers
  • F. Reagents and Controls
  • G. Current and Emerging Technologies
    • 1. Information Technologies
    • 2. Automation and Robotics
    • 3. Lasers
    • 4. Artificial Intelligence
    • 5. Monoclonal Antibodies
    • 6. Molecular Diagnostics
    • 7. Microdrop Technology

III. France : Forecasts by Test and Market Segment

IV. Germany : Forecasts by Test and Market Segment

V. Italy : Forecasts by Test and Market Segment

VI. Spain : Forecasts by Test and Market Segment

VII. U.K. : Forecasts by Test and Market Segment

VIII. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for the Decentralized Testing Markets
    • 1. Four Marketing Approaches
    • 2. Product Complexity Factor
    • 3. Customer Preference Factor
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

IX. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

X. Competitive Assessments

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • Horiba
  • Iris/Danaher
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex

XI. Appendix: Major Universities and Research Centers Developing Hematology/Flow Cytometry Technologies and Applications

List of Tables

  • France, Hospital Laboratories Estimated Cell Surface Marker Test Volume
  • France, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
  • France, Flow Cytometry Consumables Market By Major Supplier
  • France, Flow Cytometry Instrument Market By Major Supplier
  • France, Flow Cytometry Diagnostics Market By Major Supplier
  • Germany, Hospital Laboratories Estimated Cell Surface Marker Test Volume
  • Germany, Flow Cytometry Consumables Market By Major Supplier
  • Germany, Flow Cytometry Instrument Market By Major Supplier
  • Germany, Flow Cytometry Diagnostics Market By Major Supplier
  • Italy, Hospital Laboratories Estimated Cell Surface Marker Test Volume
  • Italy, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
  • Italy, Flow Cytometry Consumables Market By Major Supplier
  • Italy, Flow Cytometry Instrument Market By Major Supplier
  • Italy, Flow Cytometry Diagnostics Market By Major Supplier
  • Spain, Hospital Laboratories Estimated Cell Surface Marker Test Volume
  • Spain, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
  • Spain, Ambulatory Care Center Estimated Cell Surface Marker Test Volume
  • Spain, Flow Cytometry Consumables Market By Major Supplier
  • Spain, Flow Cytometry Instrument Market By Major Supplier
  • Spain, Flow Cytometry Diagnostics Market By Major Supplier
  • U.K., Hospital Laboratories Estimated Cell Surface Marker Test Volume
  • U.K., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
  • U.K., Flow Cytometry Consumables Market By Major Supplier
  • U.K., Flow Cytometry Instrument Market By Major Supplier
  • U.K., Flow Cytometry Diagnostics Market By Major Supplier
Back to Top